Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapy.

MLA

Safinejad, Moosareza, et al. “Lanthanum-Based Metal Organic Framework (La-MOF) Use of 3,4-Dihydroxycinnamic Acid as Drug Delivery System Linkers in Human Breast Cancer Therapy.” BMC Chemistry, vol. 16, no. 1, Nov. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13065-022-00886-y.

APA

Safinejad, M., Rigi, A., Zeraati, M., Heidary, Z., Jahani, S., Chauhan, N. P. S., & Sargazi, G. (2022). Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapy. BMC Chemistry, 16(1), 1–9. https://doi.org/10.1186/s13065-022-00886-y

Chicago

Safinejad, Moosareza, Amir Rigi, Malihe Zeraati, Zohreh Heidary, Shohreh Jahani, Narendra Pal Singh Chauhan, and Ghasem Sargazi. 2022. “Lanthanum-Based Metal Organic Framework (La-MOF) Use of 3,4-Dihydroxycinnamic Acid as Drug Delivery System Linkers in Human Breast Cancer Therapy.” BMC Chemistry 16 (1): 1–9. doi:10.1186/s13065-022-00886-y.